Navigation Links
Do anaesthetics trigger stress?
Date:9/24/2013

New research could improve the welfare standards of millions of fish used by scientists around the world. The study, published in PLOS ONE, is one of the first to formally assess the welfare implications of anaesthetics on fish. Researchers use fish to study the developmental origins of health and disease.

The work, carried out in collaboration between the University of Bristol's School of Veterinary Sciences and AstraZeneca Brixham Environmental Laboratory, investigated whether scientists are using the right anaesthetics and if current best practice for fish could be improved.

The research team's behavioural study evaluated nine of the most commonly used anaesthetics and performed preference tests using adult mixed sex zebrafish (Danio rerio), the most commonly held laboratory fish, to record their responses. Video tracking software measured swimming behaviour related to dislike for each anaesthetic at 50 per cent of its standard recommended dose compared with clean water in a flow-through chemotaxic choice chamber.

The aim of the research was to find out if anaesthetic compounds cause changes in the swimming behaviour of the zebrafish and whether the potential stress induced in these animals is inhumane.

Zebrafish embryos are transparent and develop outside the body, allowing simple study of the developing embryo. Zebrafish research provides a unique visual approach to understanding the developmental defects in adult diseases and age-related abnormalities, such as cardiovascular diseases.

Dr Jo Murrell, Senior Lecturer in Veterinary Anaesthesia at the Vet School and co-author on the study with Gareth Readman, Bristol PhD student and fish biologist at AstraZeneca, said: "Zebrafish are the most commonly used fish in universities and research organisations. There is a need to use anaesthetics to help handle them, collect samples, or humanely euthanise them.

"With tens of millions of fish used in science around the world, it is very important that the anaesthetics used to do this are the most humane available and do not themselves cause a stress response. "

The team found that several commonly used anaesthetics were aversive, including two of the most commonly recommended and used: MS222 (ethyl 3-aminobenzoate methanesulphate) and benzocaine. For ethical best practice, it is recommended that compounds that are aversive, even at low concentration, should no longer be used routinely for anaesthesia or for the first step of humane euthanasia of adult zebrafish.

Two agents were found not to induce aversive behavioural responses: etomidate and 2,2,2 tribromoethanol.

For the millions of adult zebrafish used in laboratories and breeding worldwide, the research team found the anaesthetic etomidate appears best suited for future routine humane use.

There have been advancements in general veterinary anaesthesia for mammals, but fish have been left behind and the research team hope this work will begin to re-address that balance.


'/>"/>

Contact: Joanne Fryer
joanne.fryer@bristol.ac.uk
44-011-733-17276
University of Bristol
Source:Eurekalert

Related biology news :

1. A single stem cell mutation triggers fibroid tumors
2. NIH-led study finds genetic test results do not trigger increased use of health services
3. Scientists discover new trigger for immense North Atlantic plankton bloom
4. Deadly liver cancer may be triggered by cells changing identity, UCSF study shows
5. Common parasite may trigger suicide attempts
6. Finding triggers of birth defects in an embryo heart
7. NIH-funded researchers show possible trigger for MS nerve damage
8. Rice uses light to remotely trigger biochemical reactions
9. Newly discovered scarecrow gene might trigger big boost in food production
10. Popular energy drinks trigger caffeine jitters
11. Key protein revealed as trigger for stem cell development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  EyeLock LLC, a leader of iris-based identity ... biometric solution on the latest Qualcomm® Snapdragon™ 835 ... World Congress 2017 (February 27 – March ... 3, Stand 3E10. The Snapdragon ... platform—a combination of hardware, software and biometrics ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... ... exhibits both viscous and elastic characteristics when deformed, which is identical to how ... to gently absorb compressive forces and return to its natural state along a ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology: